United Kingdom

Manas Mishra

Podimetrics completes $13.4 million funding for disease-detecting foot mat

09 May 2019

Podimetrics, the maker of a smart foot mat that detects warning signs of diabetic foot ulcers, said on Thursday it raised $13.4 million in a funding round led by a group of investors, including venture capital firm Scientific Health Development.

Allergan CEO says company is urgently looking at all options to boost share price

07 May 2019

Allergan Plc Chief Executive Brent Saunders said on Tuesday that he and the board of directors were looking with a sense of urgency at all options to revive the Botox maker's falling share price, but a lack of specifics failed to boost investor sentiment.

High levels of sunscreen ingredients end up in the bloodstream: study

06 May 2019

The active ingredients of commonly-used sunscreens end up in the bloodstream at much higher levels than current U.S. guidelines from health regulators and warrant further safety studies, according to a small study conducted by U.S. Food and Drug Administration researchers and published on Monday.

Teens with chronic pain may find support on YouTube

01 May 2019

(Reuters Health) - Teens with painful chronic illnesses may find that YouTube can provide a support network, a new study suggests.

CVS Health raises full-year profit forecast on Aetna strength

01 May 2019

CVS Health Corp on Wednesday raised its full-year profit forecast and reported first-quarter earnings that topped Wall Street estimates due to growth in its Aetna health insurance business, and as drug prices fell within its expectations.

Merck raises full-year forecasts as vaccines power profit beat

30 Apr 2019

Merck & Co Inc reported higher-than-expected first-quarter profit on Tuesday on increased demand for vaccines and cancer immunotherapy Keytruda, and the U.S. drugmaker raised its 2019 earnings and revenue forecasts.

Sleepy athletes may face higher concussion risk

25 Apr 2019

(Reuters Health) - College athletes may face a higher risk for sport-related concussions if they have insomnia or even if they're just chronically sleepy, a new study suggests.

Gilead experimental NASH drug fails another study

25 Apr 2019

Gilead Sciences Inc's experimental drug aimed at treating a type of fatty liver disease known as NASH failed to meet the main goal of a late-stage study on Thursday, two months after it failed another trial.

Boston Scientific trims 2019 sales growth forecast on weak first quarter, shares fall

24 Apr 2019

Boston Scientific Corp on Wednesday posted a rare first-quarter profit and revenue miss and lowered the top end of its 2019 sales growth forecast as the medical device maker faces regulatory scrutiny for some of its products.

Teva stops testing its migraine drug as cluster headache treatment

23 Apr 2019

Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found the treatment was unlikely to meet the main goal of a late-stage trial.

World News